A Three Part Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of Repeat Escalating Oral Doses of GSK580416; the Safety, Tolerability, and Pharmacokinetics of GSK580416 Following a Loading Dose Regimen; and the Effect of Ketoconazole on the Pharmacokinetics of GSK580416
Phase of Trial: Phase I
Latest Information Update: 01 Feb 2017
At a glance
- Drugs GSK 580416 (Primary) ; Ketoconazole
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacokinetics
- 10 Jun 2008 New trial record.